Literature DB >> 19949342

The p38 MAPK pathway is critical for 5,5'-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells.

Kyeong-Hee Choi1, Hyung-Kook Kim, Jun-Hee Kim, Eun-Sun Choi, Ji-Ae Shin, Syng-Ook Lee, Sudhakar Chintharlapalli, Stephen Safe, Maen Abdelrahim, Gu Kong, Hong Seok Choi, Ji-Youn Jung, Hyun-Tae Cho, Nam-Pyo Cho, Sung-Dae Cho.   

Abstract

Cruciferous vegetables contain isothiocyanates including diindolylmethane (DIM) that exhibit cancer chemopreventive effects. We developed a series of synthetic ring-substituted DIM analogs including 5,5'-dibromoDIM that exhibited better inhibitory activity in breast and colon cancer cells than DIM. In this study, we investigated whether 5,5'-dibromoDIM inhibits the proliferation of KB and YD-10B oral squamous carcinoma cell lines. 5,5'-dibromoDIM decreased the cell survival and inhibited the growth of oral cancer cells. Exposure of KB and YD-10B cells to 5,5'-dibromoDIM induced caspase-dependent apoptosis evidenced by poly-ADP ribose polymerase cleavage, accumulation of sub-G1 population, and nuclear condensation and fragmentation. In addition, apoptotic cell death was correlated with damage to the mitochondrial membrane potential through a decrease in the level of Bcl-2 protein expression. Mechanistic studies showed that mitochondria-dependent apoptosis induced by 5,5'-dibromoDIM was mediated by the p38 mitogen-activated protein kinase pathway but not the ERK1/2 and JNK pathway. These results highlight 5,5'-dibromoDIM as an important chemopreventive agent for the clinical treatment of oral cancer through the p38 mitogen-activated protein kinase pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19949342     DOI: 10.1097/CEJ.0b013e328333d088

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  6 in total

1.  Carnosic acid, a rosemary phenolic compound, induces apoptosis through reactive oxygen species-mediated p38 activation in human neuroblastoma IMR-32 cells.

Authors:  Chia-Wen Tsai; Chia-Yuan Lin; Hui-Hsuan Lin; Jing-Hsien Chen
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

Review 2.  Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

Authors:  Sanjeev Banerjee; Dejuan Kong; Zhiwei Wang; Bin Bao; Gilda G Hillman; Fazlul H Sarkar
Journal:  Mutat Res       Date:  2011-06-15       Impact factor: 2.433

Review 3.  Targeting the unfolded protein response in head and neck and oral cavity cancers.

Authors:  Daniel W Cole; Peter F Svider; Kerolos G Shenouda; Paul B Lee; Nicholas G Yoo; Thomas M McLeod; Sean A Mutchnick; George H Yoo; Randal J Kaufman; Michael U Callaghan; Andrew M Fribley
Journal:  Exp Cell Res       Date:  2019-05-07       Impact factor: 3.905

4.  Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.

Authors:  Jennifer C Melvin; Crystal Rodrigues; Lars Holmberg; Hans Garmo; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mats Lambe; Wayel Jassem; Mieke Van Hemelrijck
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

5.  Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia.

Authors:  William Weiben Zhang; Zhenqing Feng; Steven A Narod
Journal:  J Biomed Res       Date:  2014-04-20

6.  Solvent-Free Addition of Indole to Aldehydes: Unexpected Synthesis of Novel 1-[1-(1H-Indol-3-yl) Alkyl]-1H-Indoles and Preliminary Evaluation of Their Cytotoxicity in Hepatocarcinoma Cells.

Authors:  Graziella Tocco; Gloria Zedda; Mariano Casu; Gabriella Simbula; Michela Begala
Journal:  Molecules       Date:  2017-10-17       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.